<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR150/051/ERR15006951/ERR15006951_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR150/053/ERR15006953/ERR15006953_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR150/054/ERR15006954/ERR15006954_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR150/055/ERR15006955/ERR15006955_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR150/053/ERR15006953/ERR15006953_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR150/052/ERR15006952/ERR15006952_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR150/051/ERR15006951/ERR15006951_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR150/052/ERR15006952/ERR15006952_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR150/054/ERR15006954/ERR15006954_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR150/055/ERR15006955/ERR15006955_2.fastq.gz</Fastqsanger.gz></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>Philipps University Marburg</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJEB89807</full_dataset_link><long_description>A fusion of the HNH domain of CasDinG from Sulfitobacter sp. JL08 (SsCasDinG) to the characterized type IV-A1 CasDinG of Pseudomonas oleovorans (PoCasDinG) was created. An engineered catalytic active type IV-A1 CRISPR-Cas system able to processive degrade target DNA in vivo. Using whole genome sequencing we analyzed the effects on the genome reduction in E. coli BL21-AI also in comparison to the type I-Fv system of Shewanella putrefaciens in association with its CasDinG. This study provides the basis to use the type I-Fv and the engineered type IV-A1 systems as tools in genome reduction and helps to understand the DNA repair mechanisms used to fix CRISPR-Cas induced lesions.</long_description><repository>ENA</repository></additional><is_claimable>false</is_claimable><name>Engineered Type IV-A and Type I-Fv CRISPR-Cas effectors function in reduction of the Escherichia coli genome</name><description>Type IV-A and Type I-Fv application to genome reduction</description><dates><last_updated>2025-05-27</last_updated><first_public>2025-05-27</first_public></dates><accession>PRJEB89807</accession><cross_references/></HashMap>